⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15593856 | 1.00 | — | — | |
| SCHEMBL10998031 | 0.82 | CTRB1 (0.38) | — | |
| SCHEMBL235716 | 0.78 | — | — | |
| SCHEMBL1394489 | 0.78 | — | — | |
| SCHEMBL5014546 | 0.78 | — | — | |
| SCHEMBL1532582 | 0.78 | — | — | |
| SCHEMBL1394595 | 0.78 | — | — | |
| SCHEMBL1440549 | 0.76 | — | — | |
| SCHEMBL6526682 | 0.76 | — | — | |
| SCHEMBL1973714 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 45 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119744885-A | Application of Ace9 factor in enhancing activity of killing plant parasitic nematodes by using various bacillus | 华中农业大学 | 2025-04-04 | — | — | CN | disclosed |
| CN-112533904-B | Melanocortin subtype-2 receptor (MC 2R) antagonists and uses thereof | 克林提克斯医药股份有限公司 | 2024-10-29 | — | — | CN | disclosed |
| CN-112533910-B | Monoethylenically unsaturated monomers and their use | 博斯蒂克股份公司 | 2024-05-10 | — | — | CN | disclosed |
| CN-112533904-A | Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof | 克林提克斯医药股份有限公司 | 2021-03-19 | — | — | CN | disclosed |
| CN-112533910-A | Monoethylenically unsaturated monomers and their use | 博斯蒂克股份公司 | 2021-03-19 | — | — | CN | disclosed |
| EP-3350191-A1 | NUCLEOTIDE ANALOGS | The Regents of the University of California (US) | 2018-07-25 | — | — | EP | disclosed |
| WO-2017048956-A1 | NUCLEOTIDE ANALOGS | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-03-23 | — | — | WO | disclosed |
| EP-2217564-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XenoPort, Inc. (US) | 2010-08-18 | — | — | EP | disclosed |
| WO-2009093268-A1 | PROCESS FOR THE PREPARATION OF HIGHLY PURE PRULIFLOXACIN | IND-SWIFT LABORATORIES LIMITED (IN) | 2009-07-30 | — | — | WO | disclosed |
| WO-2009033054-A1 | COMPLEX PANTOIC ACID ESTER NEOPENTYL SULFONYL ESTER CYCLIZATION RELEASE PRODRUGS OF ACAMPROSATE, COMPOSITIONS THEREOF, AND METHODS OF USE | XENOPORT, INC. (US) | 2009-03-12 | — | — | WO | disclosed |
| EP-0433425-A1 | PROCESS FOR PENEMS | FARMITALIA CARLO ERBA S.r.l. (IT) | 1991-06-26 | — | — | EP | disclosed |
| EP-0408034-A1 | 3-Substituted vinyl cephalosporin derivatives | Eisai Co., Ltd. (JP) | 1991-01-16 | — | — | EP | disclosed |
| EP-0337637-A1 | 2-(Heterocyclylthio)carbapenem derivatives their preparation and their use as antibiotics | Sankyo Company Limited (JP) | 1989-10-18 | — | — | EP | disclosed |
| EP-0237084-A2 | 4-Bromomethyl-5-methyl-1,3-dioxolen-2-one, and a process for the production thereof | KANEBO, LTD. (JP) | 1987-09-16 | — | — | EP | disclosed |
| EP-0171812-A2 | Cephem derivatives | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1986-02-19 | — | — | EP | disclosed |
| EP-0124618-A1 | CEPHALOSPORIN DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND AGENTS FOR PROPHYLAXIS OR TREATMENT OF BACTERIA-INDUCED DISEASES | Kyoto Pharmaceutical Industries, Ltd. (JP) | 1984-11-14 | — | — | EP | disclosed |
| EP-0090344-A1 | 1,3-Dioxolen-2-one derivatives and process for production thereof | KANEBO, LTD. (JP) | 1983-10-05 | — | — | EP | disclosed |
| EP-0078413-A1 | Process for producing brominated 1,3-dioxolen-2-ones | KANEBO, LTD. (JP) | 1983-05-11 | — | — | EP | disclosed |
| EP-0070013-A1 | Oral absorption enhancement of carboxylic acid pharmaceuticals using (5-alkyl-2-oxo-1,3-dioxolen-4-yl)methyl ester group | MERCK & CO. INC. (US) | 1983-01-19 | — | — | EP | disclosed |
| EP-0067411-A1 | Novel quinolinecarboxylic acid derivative, process for production thereof, and antibacterial agent containing said compound as active ingredient | KANEBO, LTD. (JP) | 1982-12-22 | — | — | EP | disclosed |